miR-302a Inhibits Metastasis and Cetuximab Resistance in Colorectal Cancer by Targeting NFIB and CD44.
Sun L, Fang Y, Wang X, Han Y, Du F, Li C, Hu H, Liu H, Liu Q, Wang J, Liang J, Chen P, Yang H, Nie Y, Wu K, Fan D, Coffey RJ, Lu Y, Zhao X, Wang X.
Sun L, et al. Among authors: wang x, wang j.
Theranostics. 2019 Oct 22;9(26):8409-8425. doi: 10.7150/thno.36605. eCollection 2019.
Theranostics. 2019.
PMID: 31754405
Free PMC article.